Study Suggests LVAD As Platform For Mending Late-Stage Heart Failure
This article was originally published in The Gray Sheet
Executive Summary
Left ventricular assist devices might function as a platform for revitalizing hearts previously considered beyond repair, according to a study in the Nov. 2 New England Journal of Medicine
You may also be interested in...
CircuLite Aims To Transform HF Treatment With Miniature Blood Pump
CircuLite, a New Jersey start-up, aims to begin a U.S. clinical trial next year for a new treatment option for chronic heart failure patients
CircuLite Aims To Transform HF Treatment With Miniature Blood Pump
CircuLite, a New Jersey start-up, aims to begin a U.S. clinical trial next year for a new treatment option for chronic heart failure patients
Abiomed Paves Bridge-To-Recovery Market On Road To Destination Therapy
Abiomed is refocusing its ventricular-assist device (VAD) sales efforts on open-heart surgery instead of transplant centers to climb out of an unprofitable quarter and sequential loss of revenue